Literature DB >> 20556743

Hypoxia stimulates osteoclast formation from human peripheral blood.

Jennifer C Utting1, Adrienne M Flanagan, Andrea Brandao-Burch, Isabel R Orriss, Timothy R Arnett.   

Abstract

Active pathological bone destruction in humans often occurs in locations where oxygen tension (pO(2)) is likely to be low, for example, at the sites of tumours, inflammation, infections and fractures, or the poorly vascularized yellow fatty marrow of the elderly. We examined the effect of pO(2) on formation of osteoclasts, the cells responsible for bone resorption, in 14-day cultures of normal human peripheral blood mononuclear cells (hPBMCs) on ivory discs. Hypoxia (1-2% O(2)) caused threefold increases in the number of osteoclasts formed, compared with 20% O(2). Hypoxia also caused a twofold increase in the number of nuclei per osteoclast, leading to stimulations of resorption pit formation of up to 10-fold. Exposure to hypoxia led to stabilization of the hypoxia-inducible factors, HIF1alpha and HIF2alpha, and upregulation of vascular endothelial growth factor and interleukin-6 expression by hPBMCs. These findings help explain why extravasation of mononuclear precursors into relatively O(2)-deficient bone microenvironments could result in osteoclast formation and suggest a new mechanism for the bone loss associated with the pathophysiological conditions where hypoxia commonly occurs. Copyright 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20556743     DOI: 10.1002/cbf.1660

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  32 in total

Review 1.  The Key Role of the Blood Supply to Bone.

Authors:  Massimo Marenzana; Timothy R Arnett
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

Review 2.  Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep.

Authors:  Christine M Swanson; Steven A Shea; Katie L Stone; Jane A Cauley; Clifford J Rosen; Susan Redline; Gerard Karsenty; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2015-02       Impact factor: 6.741

3.  Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation.

Authors:  T Noguchi; K Ebina; M Hirao; T Morimoto; K Koizumi; K Kitaguchi; H Matsuoka; T Iwahashi; H Yoshikawa
Journal:  Osteoporos Int       Date:  2016-11-28       Impact factor: 4.507

4.  Acroosteolysis in systemic sclerosis: An insight into hypoxia-related pathogenesis.

Authors:  Simon Siao-Pin; Laura-Otilia Damian; Laura Mirela Muntean; Simona Rednic
Journal:  Exp Ther Med       Date:  2016-10-05       Impact factor: 2.447

5.  [Bone resorption in posttraumatic dystrophy. Root cause analysis based on the literature].

Authors:  A Scola; E Scola
Journal:  Unfallchirurg       Date:  2014-10       Impact factor: 1.000

6.  Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates with Progression of Human Myeloma.

Authors:  Alberto L Horenstein; Valeria Quarona; Denise Toscani; Federica Costa; Antonella Chillemi; Vito Pistoia; Nicola Giuliani; Fabio Malavasi
Journal:  Mol Med       Date:  2016-10-13       Impact factor: 6.354

7.  Bone mineral density in patients with obstructive sleep apnea syndrome.

Authors:  Hulya Uzkeser; Kadir Yildirim; Bulent Aktan; Saliha Karatay; Hasan Kaynar; Omer Araz; Korhan Kilic
Journal:  Sleep Breath       Date:  2012-04-02       Impact factor: 2.816

8.  Estrogen-mimicking isoflavone genistein prevents bone loss in a rat model of obstructive sleep apnea-hypopnea syndrome.

Authors:  Lige Song; Xiao Liang; Yun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

9.  Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model.

Authors:  Duan Chen; Julie M Roda; Clay B Marsh; Timothy D Eubank; Avner Friedman
Journal:  Bull Math Biol       Date:  2012-10-17       Impact factor: 1.758

10.  Association of Acroosteolysis With Enhanced Osteoclastogenesis and Higher Blood Levels of Vascular Endothelial Growth Factor in Systemic Sclerosis.

Authors:  Jin Kyun Park; Andrea Fava; John Carrino; Filippo Del Grande; Antony Rosen; Francesco Boin
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.